- Home
- CCCC vs QIPT Comparison
CCCC vs QIPT Comparison
Compare CCCC & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- QIPT
- Stock Information
- Founded
- CCCC 2015
- QIPT 1993
- Country
- CCCC United States
- QIPT United States
- Employees
- CCCC N/A
- QIPT N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- QIPT
- Sector
- CCCC Health Care
- QIPT
- Exchange
- CCCC Nasdaq
- QIPT Nasdaq
- Market Cap
- CCCC 115.0M
- QIPT 92.2M
- IPO Year
- CCCC 2020
- QIPT N/A
- Fundamental
- Price
- CCCC $1.47
- QIPT $1.93
- Analyst Decision
- CCCC Buy
- QIPT Buy
- Analyst Count
- CCCC 3
- QIPT 2
- Target Price
- CCCC $12.00
- QIPT $2.85
- AVG Volume (30 Days)
- CCCC 943.9K
- QIPT 2.5M
- Earning Date
- CCCC 07-31-2025
- QIPT 05-12-2025
- Dividend Yield
- CCCC N/A
- QIPT N/A
- EPS Growth
- CCCC N/A
- QIPT N/A
- EPS
- CCCC N/A
- QIPT N/A
- Revenue
- CCCC $39,783,000.00
- QIPT $240,848,000.00
- Revenue This Year
- CCCC N/A
- QIPT $3.35
- Revenue Next Year
- CCCC N/A
- QIPT $5.39
- P/E Ratio
- CCCC N/A
- QIPT N/A
- Revenue Growth
- CCCC 98.56
- QIPT N/A
- 52 Week Low
- CCCC $1.09
- QIPT $1.35
- 52 Week High
- CCCC $7.66
- QIPT $4.07
- Technical
- Relative Strength Index (RSI)
- CCCC 51.01
- QIPT 51.05
- Support Level
- CCCC $1.21
- QIPT $1.69
- Resistance Level
- CCCC $1.57
- QIPT $2.13
- Average True Range (ATR)
- CCCC 0.12
- QIPT 0.16
- MACD
- CCCC 0.02
- QIPT 0.04
- Stochastic Oscillator
- CCCC 70.27
- QIPT 66.67
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.